The Ganesha Lab

The Ganesha Lab focuses on science-driven, early-stage startups originating from Latin American research institutions. Its mandate covers biotechnology, digital health, agritech and foodtech — sectors where the region has raw scientific assets. Companies typically enter through a structured acceleration program before receiving seed investment.

The firm operates a cohort-based acceleration program that combines a fixed-term curriculum with initial capital, mentorship, and access to lab and pilot infrastructure. Startups that complete the program successfully may receive a follow-on seed-stage investment. This model is distinct from pure venture funds that invest on a deal-by-deal basis without operational programming attached.

Yes, while headquartered in Santiago, the firm's mandate covers Latin America broadly. Its sourcing pipeline draws from university and research-lab networks in multiple countries, though specific country allocations have not been publicly detailed.

The Ganesha Lab combines elements of an accelerator and a seed-stage venture investor. It is not a passive limited partner in external funds; instead, it directly selects, educates, and capitalizes early-stage science startups. Whether it raises discrete fund vehicles or deploys via a holding-company or rolling-club structure has not been publicly disclosed.

The firm's founding principals and investment committee members are not publicly identified in accessible records. The Lab maintains a low public profile consistent with many early-stage Chilean investment firms that limit outward-facing disclosure to portfolio and program activity.